[HTML][HTML] 胰腺癌细胞内吉西他滨耐药机制的研究进展
顾宗廷， 李宗泽， 王成锋 - 世界华人消化杂志, 2020 - wjgnet.com
… cancer is one of the most deadly malignant tumors that endanger human health, and pancreatic
ductal adenocarcinoma (PDAC) is the most common histological type. Due to the lack of …
ductal adenocarcinoma (PDAC) is the most common histological type. Due to the lack of …
[PDF][PDF] 沉默PRLR 表达增加胰腺导管腺癌细胞的耐药性
张一帆， 黄佩琦， 孙悦， 潘泓， 盖严支， 聂惠贞 - 肿瘤, 2021 - tumorsci.org
… Wnt/β-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance[…
CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through …
CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through …
[HTML][HTML] 胰腺癌细胞外吉西他滨耐药机制的研究进展
顾宗廷， 李宗泽， 王成锋 - 世界华人消化杂志, 2021 - wjgnet.com
… 其中约90%是胰腺导管腺癌(pancreatic ductal adenocarcinoma, PDAC). 尽管手术切除是唯一
… The mechanism underlying gemcitabine resistance is complex and still unclear in PDAC. …
… The mechanism underlying gemcitabine resistance is complex and still unclear in PDAC. …
[HTML][HTML] 葡萄糖代谢重编程在胰腺癌耐药中的研究进展
喻悦， 王瑜亮， 张晓 - 南京医科大学学报(自然科学版), 2024 - jnmu.njmu.edu.cn
… suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by
secreting … in patients with pancreatic ductal adenocarcinoma[J].J Gene Med,2024,26(1):e3570 …
secreting … in patients with pancreatic ductal adenocarcinoma[J].J Gene Med,2024,26(1):e3570 …
[PDF][PDF] 胰腺导管腺癌面临的挑战与最新研究进展
邹依地， 黄承浩 - 生命科学, 2019 - core.ac.uk
… 摘要:胰腺导管腺癌(pancreatic ductal adenocarcinoma, PDAC) 是全球… FOLFIRINOX versus
gemcitabine for metastatic pancreatic … of the stroma in the intrinsic resistance to gemcitabine in …
gemcitabine for metastatic pancreatic … of the stroma in the intrinsic resistance to gemcitabine in …
[HTML][HTML] 基于生物信息学分析胰腺导管腺癌中SPP1 的表达与预后的关系及其作用机制
迂金洋， 杨向红 - 中国医科大学学报, 2023 - html.rhhz.net
… Relationship between SPP1 expression and the prognosis and its mechanism in pancreatic
ductal adenocarcinoma based on bioinformatics[J]. Journal of China Medical University, …
ductal adenocarcinoma based on bioinformatics[J]. Journal of China Medical University, …
肿瘤相关成纤维细胞在胰腺癌治疗耐药中的作用.
闫毅， 贾军梅， 郭亚荣 - Journal of Clinical Hepatology …, 2022 - search.ebscohost.com
… Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: …
Interstitial pressure in pancreatic ductal adenocarcinoma is dominated by a gel - fluid phase …
Interstitial pressure in pancreatic ductal adenocarcinoma is dominated by a gel - fluid phase …
[PDF][PDF] 长链非编码RNA 在胰腺癌吉西他滨耐药研究中的作用
郭晨博， 毛玉宁， 张延英， 汪永锋… - 中国比较医学杂志, 2022 - zgbjyx.cnjournals.com
… of various lncRNAs in gemcitabine resistance of pancreatic cancer to explore possible
therapeutic targets related to lncRNA to alleviate gemcitabine resistance of pancreatic cancer. …
therapeutic targets related to lncRNA to alleviate gemcitabine resistance of pancreatic cancer. …
[PDF][PDF] 非编码RNA 对胰腺癌发生进展及耐药的影响
吴念平， 周策凡， 唐景峰 - Life Science Research, 2023 - smkx.hunnu.edu.cn
… 为胰腺 导管癌(pancreatic ductal adenocarcinoma, PDAC)[11]. … EMT and gemcitabine
resistance in pancreatic cancer via … , contributes to pancreatic ductal adenocarcinoma epithelial-…
resistance in pancreatic cancer via … , contributes to pancreatic ductal adenocarcinoma epithelial-…
[PDF][PDF] DZ RNA ٰ չ ҩ Ӱ
WU Nianping, Z Cefan, T Jingfeng - ѧ о , 2023 - smkx.hunnu.edu.cn
… 为胰腺 导管癌(pancreatic ductal adenocarcinoma, PDAC)[11]. … EMT and gemcitabine
resistance in pancreatic cancer via … , contributes to pancreatic ductal adenocarcinoma epithelial-…
resistance in pancreatic cancer via … , contributes to pancreatic ductal adenocarcinoma epithelial-…